JPH04217692A - Production of 3'-deoxy-3'-fluorothymidine - Google Patents
Production of 3'-deoxy-3'-fluorothymidineInfo
- Publication number
- JPH04217692A JPH04217692A JP2398891A JP2398891A JPH04217692A JP H04217692 A JPH04217692 A JP H04217692A JP 2398891 A JP2398891 A JP 2398891A JP 2398891 A JP2398891 A JP 2398891A JP H04217692 A JPH04217692 A JP H04217692A
- Authority
- JP
- Japan
- Prior art keywords
- deoxy
- fluorothymidine
- reaction
- solvent
- acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- UXCAQJAQSWSNPQ-XLPZGREQSA-N Alovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](F)C1 UXCAQJAQSWSNPQ-XLPZGREQSA-N 0.000 title claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- -1 amine acetates Chemical class 0.000 claims abstract description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 10
- UVXRTMHPZXVNDJ-UYVBYVPASA-N 1-[(2r,4s,5s)-4-fluoro-5-[hydroxy(methylsulfonyl)methyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](C(O)S(C)(=O)=O)[C@@H](F)C1 UVXRTMHPZXVNDJ-UYVBYVPASA-N 0.000 claims abstract description 9
- 230000000397 acetylating effect Effects 0.000 claims abstract description 8
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000005695 Ammonium acetate Substances 0.000 claims abstract description 5
- 235000019257 ammonium acetate Nutrition 0.000 claims abstract description 5
- 229940043376 ammonium acetate Drugs 0.000 claims abstract description 5
- 239000002798 polar solvent Substances 0.000 claims abstract description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims abstract description 3
- 230000000850 deacetylating effect Effects 0.000 claims abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 14
- QZILQVQBXXCPGO-WPXGONGXSA-N 1-[(2r,4s,5r)-4-fluoro-5-(1-hydroxy-2-oxopropyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound C1[C@H](F)[C@@H](C(O)C(=O)C)O[C@H]1N1C(=O)NC(=O)C(C)=C1 QZILQVQBXXCPGO-WPXGONGXSA-N 0.000 claims description 6
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 22
- 239000007810 chemical reaction solvent Substances 0.000 abstract description 8
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 abstract description 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract description 3
- 239000001632 sodium acetate Substances 0.000 abstract description 3
- 235000017281 sodium acetate Nutrition 0.000 abstract description 3
- 239000003513 alkali Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 239000002904 solvent Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 10
- 238000006640 acetylation reaction Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 6
- MKXBOPXRKXGSTI-PJKMHFRUSA-N 1-[(2s,4s,5r)-2-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@]1(F)O[C@H](CO)[C@@H](O)C1 MKXBOPXRKXGSTI-PJKMHFRUSA-N 0.000 description 5
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 5
- 230000021736 acetylation Effects 0.000 description 5
- 239000003463 adsorbent Substances 0.000 description 5
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 5
- 229940104230 thymidine Drugs 0.000 description 5
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000003381 deacetylation reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000002777 nucleoside Substances 0.000 description 3
- 125000003835 nucleoside group Chemical group 0.000 description 3
- 235000011056 potassium acetate Nutrition 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- IRPGOXJVTQTAAN-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropanal Chemical compound FC(F)(F)C(F)(F)C=O IRPGOXJVTQTAAN-UHFFFAOYSA-N 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 2
- KLZUFWVZNOTSEM-UHFFFAOYSA-K Aluminum fluoride Inorganic materials F[Al](F)F KLZUFWVZNOTSEM-UHFFFAOYSA-K 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- JCSNHEYOIASGKU-BWZBUEFSSA-N anhydrothymidine Chemical compound C1[C@H]2OC3=NC(=O)C(C)=CN3[C@@H]1O[C@@H]2CO JCSNHEYOIASGKU-BWZBUEFSSA-N 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- FDBYXORVPVRQKN-UHFFFAOYSA-N 1,4-dioxane;hydron;fluoride Chemical compound [H+].[F-].C1COCCO1 FDBYXORVPVRQKN-UHFFFAOYSA-N 0.000 description 1
- IFWXXEDYKGUZKL-SOCHQFKDSA-N 1-[(2r,4r,5r)-4-hydroxy-5-(hydroxymethyl)-4-methylsulfonyloxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@](O)(S(C)(=O)=O)C1 IFWXXEDYKGUZKL-SOCHQFKDSA-N 0.000 description 1
- FQOVSZXEAOCCLV-QIZYPBSGSA-N 1-[(2r,4r,5r)-4-hydroxy-5-[hydroxy(methylsulfonyl)methyl]-4-methylsulfonyloxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](C(O)S(C)(=O)=O)[C@](O)(S(C)(=O)=O)C1 FQOVSZXEAOCCLV-QIZYPBSGSA-N 0.000 description 1
- JPBRYDQRCOMYRY-UHFFFAOYSA-N 3',5'-Dimesyl-Thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(COS(C)(=O)=O)C(OS(C)(=O)=O)C1 JPBRYDQRCOMYRY-UHFFFAOYSA-N 0.000 description 1
- FUTVTSDLQPMPRT-UHFFFAOYSA-N 3'-Mesyl-Thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(OS(C)(=O)=O)C1 FUTVTSDLQPMPRT-UHFFFAOYSA-N 0.000 description 1
- ASZZHBXPMOVHCU-UHFFFAOYSA-N 3,9-diazaspiro[5.5]undecane-2,4-dione Chemical compound C1C(=O)NC(=O)CC11CCNCC1 ASZZHBXPMOVHCU-UHFFFAOYSA-N 0.000 description 1
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 1
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- 229940124321 AIDS medicine Drugs 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- MCZDHTKJGDCTAE-UHFFFAOYSA-M tetrabutylazanium;acetate Chemical compound CC([O-])=O.CCCC[N+](CCCC)(CCCC)CCCC MCZDHTKJGDCTAE-UHFFFAOYSA-M 0.000 description 1
- GTCDARUMAMVCRO-UHFFFAOYSA-M tetraethylazanium;acetate Chemical compound CC([O-])=O.CC[N+](CC)(CC)CC GTCDARUMAMVCRO-UHFFFAOYSA-M 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- MRYQZMHVZZSQRT-UHFFFAOYSA-M tetramethylazanium;acetate Chemical compound CC([O-])=O.C[N+](C)(C)C MRYQZMHVZZSQRT-UHFFFAOYSA-M 0.000 description 1
- PXJUBOLFJDSAQQ-UHFFFAOYSA-M tetrapropylazanium;acetate Chemical compound CC([O-])=O.CCC[N+](CCC)(CCC)CCC PXJUBOLFJDSAQQ-UHFFFAOYSA-M 0.000 description 1
Abstract
Description
【0001】0001
【産業上の利用分野】本発明はそれ自身が抗ウイルス作
用、抗腫瘍作用を有する3’−デオキシ−3’−フルオ
ロチミジンの製造法に関する。TECHNICAL FIELD The present invention relates to a method for producing 3'-deoxy-3'-fluorothymidine, which itself has antiviral and antitumor effects.
【0002】0002
【従来の技術】近年、ヌクレオシド類が種々の生理活性
を示すことが知られ、数多くの天然型および非天然型ヌ
クレオシド類が合成されている。これらヌクレオシド類
のうち抗エイズウイルス活性を示すことで注目されてい
る3’−デオキシ−3’−フルオロチミジンを合成する
方法としては、■3’−メシルチミジンまたは2,3’
−アンハイドロチミジンとフッ化水素カリウムまたはフ
ッ化アンモニウムとを、エチレングリコール溶媒中19
1℃で10〜90分加熱反応することにより、収率10
〜14%で3’−デオキシ−3’−フルオロチミジンを
合成する方法〔特公昭48−10472号公報〕、■チ
ミジンと4−クロロベンゾイルクロライドとを、ピリジ
ン溶媒中5〜20℃で反応させ、収率80%で5’−(
4−クロロベンゾイル)チミジンとした後、5’−(4
−クロロベンゾイル)チミジンを塩化メチレン溶媒中で
、ジエチルアミノスルホトリフルオライドと−78℃で
反応し、収率19.9%で3’−デオキシ−3’−フル
オロチミジンを合成する方法〔特開平1−68325号
公報〕、■2,3’−アンハイドロチミジンとフッ酸と
をトリエチルアミン溶媒中150℃で90分加熱反応す
ることにより3’−デオキシ−3’−フルオロチミジン
と3’−デオキシ−3’−フルオロ−5’−メシルチミ
ジンの混合物を収率19%で得る方法〔Zeitsch
rift fur Chemie,第23巻、第3
35頁(1983年)〕、■2,3’−アンハイドロ−
5’−メシルチミジンをジオキサン溶媒中で、フッ酸お
よびフッ化アルミニウムと170℃で反応し、収率61
%で3’−デオキシ−3’−フルオロ−5’−メシルチ
ミジンを得たのち、水酸化ナトリウムによる脱メシル化
を行ない、収率46%で3’−デオキシ−3’−フルオ
ロチミジンを合成する方法〔Journal fur
Praktische Chemie,第315
巻、第895頁(1973年)〕が開示されている。し
かしこれらの方法は、収率が低い、あるいは高価な試薬
を使用する、あるいは再現性が悪い、あるいは精製法が
難しい等の問題点を有し、工業的な製造法としては適し
ていない。このほかの合成法としては、チミジンの5’
−位水酸基を耐酸性保護基であるメシル基(CH3SO
3−)で保護したのち、3’−位をフッ酸を用いてフッ
素化して3’−デオキシ−3’−フルオロ−5’−メシ
ルチミジン(以下「5’−メシル化体」と略称する)と
し、次いで脱メシル化を行ない3’−デオキシ−3’−
フルオロチミジンとする方法が知られている。この合成
法の工程の一つである脱メシル化反応は、通常水酸化ア
ルカリを用いたアルカリ条件下で行なわれるが、5’−
メシル化体はその構造式中に水酸化アルカリと反応し易
いフッ素を含有するため、この水酸化アルカリを用いる
脱メシル化反応を採用することはできない。従って5’
−メシル化体の脱メシル化反応としては、無水酢酸中で
酢酸カリウムを用いてメシル基をアセチル基に置換した
5’−アセチル−3’−デオキシ−3’−フルオロチミ
ジン(以下「5’−アセチル化体」と略称する)とした
のち、脱アセチル化を行なって3’−デオキシ−3’−
フルオロチミジンを得る方法〔Nucleic Ac
id Chemistry Part I、第2
99〜302頁(1978年)〕が用いられている。BACKGROUND OF THE INVENTION In recent years, it has been known that nucleosides exhibit various physiological activities, and a large number of natural and non-natural nucleosides have been synthesized. Among these nucleosides, methods for synthesizing 3'-deoxy-3'-fluorothymidine, which has attracted attention for its anti-AIDS virus activity, include: (1) 3'-mesylthymidine or 2,3'
- anhydrothymidine and potassium hydrogen fluoride or ammonium fluoride in an ethylene glycol solvent
By heating the reaction at 1°C for 10 to 90 minutes, a yield of 10
A method for synthesizing 3'-deoxy-3'-fluorothymidine at ~14% [Japanese Patent Publication No. 10472/1983], (1) Reacting thymidine and 4-chlorobenzoyl chloride at 5 to 20°C in a pyridine solvent, 5'-( with a yield of 80%
After converting to thymidine (4-chlorobenzoyl), 5'-(4
A method for synthesizing 3'-deoxy-3'-fluorothymidine in a yield of 19.9% by reacting thymidine (chlorobenzoyl) with diethylaminosulfotrifluoride in a methylene chloride solvent at -78°C 68325], ■ 3'-deoxy-3'-fluorothymidine and 3'-deoxy-3' are produced by heating reaction of 2,3'-anhydrothymidine and hydrofluoric acid at 150°C for 90 minutes in a triethylamine solvent. - Method for obtaining a mixture of fluoro-5'-mesylthymidine in a yield of 19% [Zeitsch
rift fur Chemie, Volume 23, No. 3
35 pages (1983)], ■2,3'-Anhydro-
5'-Mesylthymidine was reacted with hydrofluoric acid and aluminum fluoride in dioxane solvent at 170°C, yield 61
After obtaining 3'-deoxy-3'-fluoro-5'-mesylthymidine in %, demesylation with sodium hydroxide is performed to synthesize 3'-deoxy-3'-fluorothymidine in a yield of 46%. Method [Journal fur
Praktische Chemie, No. 315
Vol., p. 895 (1973)]. However, these methods have problems such as low yield, use of expensive reagents, poor reproducibility, and difficult purification methods, and are not suitable as industrial production methods. Other synthetic methods include the 5' of thymidine.
The hydroxyl group at the -position is replaced by a mesyl group (CH3SO), which is an acid-resistant protecting group.
3-), and then fluorinated the 3'-position using hydrofluoric acid to obtain 3'-deoxy-3'-fluoro-5'-mesylthymidine (hereinafter abbreviated as "5'-mesylated product"). and then demesylated to give 3'-deoxy-3'-
A method of using fluorothymidine is known. The demesylation reaction, which is one of the steps in this synthetic method, is usually carried out under alkaline conditions using alkali hydroxide.
Since the mesylated product contains fluorine in its structural formula, which easily reacts with alkali hydroxide, a demesylation reaction using this alkali hydroxide cannot be employed. Therefore 5'
- For the demesylation reaction of the mesylated product, 5'-acetyl-3'-deoxy-3'-fluorothymidine (hereinafter referred to as "5'- 3'-deoxy-3'-
How to obtain fluorothymidine [Nucleic Ac
id Chemistry Part I, 2nd
99-302 (1978)] is used.
【0003】0003
【発明が解決しようとする課題】従来の無水酢酸中での
5’−メシル化体のアセチル化反応は、5’−メシル化
体に対して約100倍量の無水酢酸を用い、かつ長時間
加熱するために、反応物は著しく着色し、副反応物も多
量に生成し、5’−アセチル化体の収率は極めて低い。
従って精製も効率の悪いカラムクロマト法が必須となる
ため、工業的に大量の5’−アセチル化体を製造するこ
とは困難である。[Problems to be Solved by the Invention] The conventional acetylation reaction of a 5'-mesylated product in acetic anhydride uses about 100 times the amount of acetic anhydride relative to the 5'-mesylated product, and requires a long reaction time. Due to the heating, the reactants are markedly colored, a large amount of side reactants are produced, and the yield of the 5'-acetylated product is extremely low. Therefore, since column chromatography, which is inefficient for purification, is essential, it is difficult to industrially produce large quantities of 5'-acetylated products.
【0004】0004
【課題を解決するための手段】本発明者らは5’−メシ
ル化体の効率のよいアセチル化について検討を重ねた結
果、5’−メシル化体と酢酸アルカリ金属塩、酢酸アミ
ン類および酢酸アンモニウムからなる群より選択される
アセチル化試薬の両者を溶解する溶媒中で、アセチル化
が容易に進行することに着目し、反応溶媒として非プロ
トン性溶媒を選択することにより、無水酢酸を必要とし
ない本発明のアセチル化条件を見い出したものである。
すなわち本発明は下式に示すように、原料である5’−
メシル化体を非プロトン性極性溶媒中で、酢酸アルカリ
金属塩、酢酸アミン類および酢酸アンモニウムからなる
群より選択されるアセチル化試薬と反応させることによ
り5’−アセチル化体としたのち、5’−位のアセチル
基の脱離反応を行って目的とする3’−デオキシ−3’
−フルオロチミジンを得るものである。(以下余白)[Means for Solving the Problems] As a result of repeated studies on efficient acetylation of 5'-mesylated products, the present inventors found that 5'-mesylated products, alkali metal salts of acetate, amine acetates, and acetic acid Focusing on the fact that acetylation proceeds easily in a solvent that dissolves both acetylation reagents selected from the group consisting of ammonium, we selected an aprotic solvent as the reaction solvent, thereby eliminating the need for acetic anhydride. We have discovered the acetylation conditions of the present invention that do not. In other words, as shown in the formula below, the present invention provides 5'-
The mesylated product is reacted with an acetylating reagent selected from the group consisting of alkali metal acetates, amine acetates, and ammonium acetate in an aprotic polar solvent to form a 5'-acetylated product, and then the 5' The target 3'-deoxy-3' is obtained by eliminating the acetyl group at the -position.
- fluorothymidine is obtained. (Margin below)
【
0005】[
0005
【化1】 3’−デオキシ−3’−フルオロチミジン[Chemical formula 1] 3'-deoxy-3'-fluorothymidine
【0006】
本発明の原料である5’−メシル化体は、Nuclei
c Acid Chemistry Part
I,第299頁(1978年)に記載されているよう
に、ピリジン溶媒中でチミジンにメシルクロライドを反
応させて、3’,5’−ジメシルチミジンとしたのち、
エタノール溶媒中で水酸化ナトリウムと反応させて2,
3’−アンハイドロ−5’−メシルチミジンとし、次い
で、0.1%フッ酸ジオキサン溶媒中でフッ化アルミニ
ウムと加熱下に反応することにより得ることができる。
本発明で用いるアセチル化試薬は酢酸アルカリ金属塩、
酢酸アミン類および酢酸アンモニウムであり、具体的に
は酢酸アルカリ金属塩では酢酸リチウム、酢酸ナトリウ
ム、酢酸カリウムなどが、酢酸アミン類としては酢酸=
テトラメチルアンモニウム、酢酸=テトラエチルアンモ
ニウム、酢酸=テトラプロピルアンモニウム、酢酸=テ
トラブチルアンモニウムなどの酢酸のテトラアルキルア
ンモニウムなどが例示できる。反応溶媒としては非プロ
トン性極性溶媒が用いられ、N,N−ジメチルホルムア
ミド、N,N−ジメチルアセトアミド、ジメチルスルホ
キシド、ヘキサメチルリン酸トリアミドなどが例示でき
るが、これらに限定されるものではない。本発明の5’
−メシル化体のアセチル化反応は、5’−メシル化体に
対し最少限等モルのアセチル化試薬を必要とし、通常は
1.4〜3倍モルが最適である。アセチル化試薬を過剰
に用いると反応系が酸性となるため好ましくない。
非プロトン性極性溶媒の量は、5’−メシル化体が溶解
していればよく、アセチル化試薬の一部が懸濁状態であ
っても反応は進行するが、通常は5’−メシル化体の等
量(重量)以上が好ましい。反応温度は50℃以上あれ
ばよく反応溶媒の沸点以下で行なう。50℃以下ではア
セチル化反応の進行がきわめて遅くなり、反応溶媒の沸
点近くになると反応物が着色することもあるので、80
〜130℃が最も好ましい温度範囲である。反応時間は
反応温度や反応溶媒の種類、アセチル化試薬の種類によ
り異なるが、110℃では10〜120分を要する。反
応終了後、反応物はそのまま次工程の脱アセチル化反応
に用いてもよく、また反応物より減圧下に反応溶媒を除
去した反応濃縮物の状態で脱アセチル化反応に用いても
よい。また、反応物または反応濃縮物より5’−アセチ
ル化物を有機溶剤で抽出し、溶剤を留去した濃縮物をそ
のまま、あるいは濃縮物を活性炭による脱色処理を行な
うなどの精製処理ののち脱アセチル化反応に用いること
もできる。次に、このようにして得られた5’−アセチ
ル化体を既知のアセチル基の脱離反応、例えばアンモニ
ア飽和メタノール中で0℃〜室温に放置または撹拌する
こと〔Nucleic Acid Chemist
ry Part I,第299頁(1978年)〕
で脱アセチル化は終了する。反応終了後、活性炭により
脱色処理を行い灰白色結晶の粗3’−デオキシ−3’−
フルオロチミジンを得、さらに水、低級アルコール、酢
酸エチルを用いた再結晶法などの精製処理を行なう、あ
るいは反応液より減圧下に反応溶媒を留去した後、合成
吸着剤で処理して3’−デオキシ−3’−フルオロチミ
ジンを吸着させ、次いでアルコール−水混液で溶出し、
溶媒留去、水、低級アルコールを用いた再結晶による精
製処理を行なうことにより、白色粉末状あるいは白色粒
状結晶の純度99.8%以上の3’−デオキシ−3’−
フルオロチミジンを70%以上の高収率で得るものであ
る。[0006]
The 5'-mesylated compound that is the raw material of the present invention is Nuclei
c Acid Chemistry Part
I, p. 299 (1978), after reacting thymidine with mesyl chloride in a pyridine solvent to give 3',5'-dimesylthymidine,
2, by reacting with sodium hydroxide in ethanol solvent.
It can be obtained by preparing 3'-anhydro-5'-mesylthymidine and then reacting it with aluminum fluoride in a 0.1% hydrofluoric acid dioxane solvent under heating. The acetylation reagent used in the present invention is an acetic acid alkali metal salt,
These are amine acetates and ammonium acetate. Specifically, alkali metal acetates include lithium acetate, sodium acetate, potassium acetate, etc., and amine acetates include acetic acid =
Examples include tetraalkylammonium acetic acid such as tetramethylammonium, tetraethylammonium acetate, tetrapropylammonium acetate, and tetrabutylammonium acetate. As the reaction solvent, an aprotic polar solvent is used, and examples thereof include N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulfoxide, and hexamethylphosphoric triamide, but are not limited thereto. 5' of the present invention
The acetylation reaction of the -mesylated product requires a minimum equimolar amount of the acetylating reagent relative to the 5'-mesylated product, and usually 1.4 to 3 times the mole is optimal. Excessive use of the acetylating reagent is not preferred because the reaction system becomes acidic. The amount of aprotic polar solvent is sufficient as long as the 5'-mesylated compound is dissolved, and the reaction will proceed even if a part of the acetylating reagent is in a suspended state, but usually 5'-mesylated It is preferable that the amount is equal to or more than the body weight. The reaction temperature may be 50° C. or higher and is preferably carried out at a temperature lower than the boiling point of the reaction solvent. At temperatures below 50°C, the acetylation reaction progresses extremely slowly, and when the temperature approaches the boiling point of the reaction solvent, the reactants may become colored.
-130°C is the most preferred temperature range. The reaction time varies depending on the reaction temperature, the type of reaction solvent, and the type of acetylating reagent, but at 110°C, it takes 10 to 120 minutes. After the reaction is completed, the reaction product may be used as it is in the next step of deacetylation reaction, or it may be used in the deacetylation reaction in the form of a reaction concentrate obtained by removing the reaction solvent from the reaction product under reduced pressure. In addition, the 5'-acetylated product can be extracted from the reactant or reaction concentrate with an organic solvent, and the concentrate after distilling off the solvent can be used as it is, or the concentrate can be deacetylated after purification treatment such as decolorization with activated carbon. It can also be used in reactions. Next, the 5'-acetylated product thus obtained is subjected to a known acetyl group elimination reaction, for example, by standing or stirring in ammonia-saturated methanol at 0°C to room temperature [Nucleic Acid Chemist
ry Part I, page 299 (1978)]
The deacetylation ends. After the reaction is completed, decolorization treatment is performed using activated carbon to obtain crude 3'-deoxy-3'- as gray-white crystals.
Fluorothymidine is obtained and further purified by a recrystallization method using water, a lower alcohol, or ethyl acetate, or after the reaction solvent is distilled off from the reaction solution under reduced pressure, it is treated with a synthetic adsorbent to obtain 3'-Deoxy-3'-fluorothymidine is adsorbed, then eluted with an alcohol-water mixture,
By performing purification treatment by distilling off the solvent and recrystallizing using water and lower alcohol, 3'-deoxy-3'- is produced in the form of white powder or white granular crystals with a purity of 99.8% or more.
Fluorothymidine can be obtained in a high yield of 70% or more.
【0007】[0007]
【実施例】以下、実施例により本発明を例示する。実施
例13’−デオキシ−3’−フルオロ−5’−メシルチ
ミジン3.22g(10mmol)をジメチルスルホキ
シド10mlに溶解する。この溶液に酢酸ナトリウム1
.64g(20mmol)を加え、110°±5℃で1
0分間撹拌下に加熱した。反応終了後、反応混合物より
減圧下にジメチルスルホキシドを留去し、残渣として淡
褐色油状物約5gを得た。この淡褐色油状物は5’−ア
セチル−3’−デオキシ−3’−フルオロチミジンの標
品と、高速液体クロマトグラフィーにおいて同一の保持
時間を与え、薄層クロマトグラフィーにおいても同一の
Rf値を与えた。また、核磁気共鳴スペクトルにおいて
もメシル基に帰属されるδ値3.25ppmのピークは
消失し、アセチル基に帰属されるδ値2.09ppmの
ピークの生成を確認したことにより、5′−アセチル−
3’−デオキシ−3’−フルオロチミジンであることを
確認した。次に、この淡褐色油状物にアンモニア飽和メ
タノール溶液60mlを加え、室温で約2時間撹拌後、
減圧下にメタノールを留去し、淡赤褐色油状物を得た。
この赤褐色油状物に水10mlを加え加熱溶解後、活性
炭を加え脱色し、熱時濾過する。これを更に熱湯10m
lで洗浄し、先の濾液と合わせて減圧下に水を留去する
。残渣に水10mlを加えて加熱溶解後、室温で一夜放
置し、白色粒状結晶の3’−デオキシ−3’−フルオロ
チミジン2.0g(8.2m mol)を得た。収率
82%。[Examples] The present invention will be illustrated below with reference to Examples. Example 1 3.22 g (10 mmol) of 3'-deoxy-3'-fluoro-5'-mesylthymidine is dissolved in 10 ml of dimethyl sulfoxide. Add 1 part of sodium acetate to this solution.
.. Add 64g (20mmol) and heat at 110°±5°C.
Heat with stirring for 0 minutes. After the reaction was completed, dimethyl sulfoxide was distilled off from the reaction mixture under reduced pressure to obtain about 5 g of a pale brown oil as a residue. This light brown oil gave the same retention time in high performance liquid chromatography as the standard 5'-acetyl-3'-deoxy-3'-fluorothymidine, and gave the same Rf value in thin layer chromatography. Ta. In addition, in the nuclear magnetic resonance spectrum, the peak with a δ value of 3.25 ppm attributed to the mesyl group disappeared, and the generation of a peak with a δ value of 2.09 ppm attributed to the acetyl group was confirmed. −
It was confirmed that it was 3'-deoxy-3'-fluorothymidine. Next, 60 ml of ammonia saturated methanol solution was added to this light brown oil, and after stirring at room temperature for about 2 hours,
Methanol was distilled off under reduced pressure to obtain a light reddish brown oil. Add 10 ml of water to this reddish-brown oil, heat and dissolve, then add activated carbon to decolorize and filter while hot. Add this to 10 m of boiling water.
The mixture is combined with the previous filtrate and the water is distilled off under reduced pressure. After adding 10 ml of water to the residue and dissolving it under heating, it was left to stand at room temperature overnight to obtain 2.0 g (8.2 mmol) of 3'-deoxy-3'-fluorothymidine in the form of white granular crystals. Yield 82%.
【0008】分析値
(1)3’−デオキシ−3’−フルオロ−5’−メシル
チミジン
融点:165〜166℃
1H−核磁気共鳴スペクトル(DMSO−
d6) δ(ppm)=1.77(s,3H
,CH3)
2.39(m,2H,H−2’×2)
3.25(s,3H,CH3
SO2−)
4.38(m,1H,H−4’)
4.42(m,2H,H−5’×
2) 5.3
7(dd,JHH=4.0HZ,JHF=52.2HZ
,
1H,H−3’)
6.24(dd,J=8.6HZ,
J=6.0HZ,1H,
H−1’)
7.51(s,1H
,6−H) 11
.40(brS,1H,>NH) 13C−
核磁気共鳴スペクトル(DMSO−d6)
δ(ppm)=11.94(CH3)
36.08(d,J=20.
7HZ,2’−C)
36.76(CH3SO2−)
68.83(d,J=11
.2HZ,5’−C)
81.39(d,J=26.9HZ,4’−
C) 84.
45(1’−C)
93.86(d,J=176.6HZ,3’−C
) 110.37
(5−C) 13
5.88(6−C)
150.80(2−C)
160.98(4−C)Analysis value (1) 3'-deoxy-3'-fluoro-5'-mesylthymidine Melting point: 165-166°C 1H-nuclear magnetic resonance spectrum (DMSO-
d6) δ (ppm) = 1.77 (s, 3H
,CH3)
2.39 (m, 2H, H-2'×2)
3.25(s,3H,CH3
SO2-)
4.38 (m, 1H, H-4')
4.42(m, 2H, H-5'×
2) 5.3
7 (dd, JHH=4.0HZ, JHF=52.2HZ
,
1H,H-3')
6.24 (dd, J=8.6HZ,
J=6.0HZ, 1H,
H-1')
7.51(s, 1H
,6-H) 11
.. 40(brS, 1H, >NH) 13C-
Nuclear magnetic resonance spectrum (DMSO-d6)
δ (ppm) = 11.94 (CH3)
36.08 (d, J=20.
7HZ, 2'-C)
36.76(CH3SO2-)
68.83 (d, J=11
.. 2HZ,5'-C)
81.39 (d, J=26.9HZ, 4'-
C) 84.
45 (1'-C)
93.86 (d, J=176.6HZ, 3'-C
) 110.37
(5-C) 13
5.88 (6-C)
150.80 (2-C)
160.98 (4-C)
【0009】
(2)5’−アセチル−3’−デオキシ−3’−フルオ
ロチミジン
融点:99〜100℃
1H−核磁気共鳴スペクトル(DMSO=
d6) δ(ppm)=1.90(d,J=
1.22HZ,3H,CH3)
2.09(s,3H,CH3CO−
) 2.23
(m,1H,2’−H)
2.62(m,1H,2’−H)
4.36(m,2H
,5’−H)
4.37(m,1H,4’−H)
5.18(dd,JHH=5.
3HZ,JHF=51.6HZ,
3’−H)
6.30(
dd,J=8.8HZ,J=55HZ,1’−H)
7.22(d,
J=1.22HZ,6−H)
9.21(brS,1H,>NH)
13C−核磁気共鳴スペクトル(DMSO−
d6) δ(ppm)=12.43(CH3
) 20.5
5(CH3CO−)
38.12(d,J=21.3HZ,2’−C
) 63.4
4(d,J=10.2HZ,5’−C)
82.37(d,J=26
.7HZ,4’−C)
85.47(1’−C)
93.44(d,J=180.
6HZ,3’−C)
111.57(5−C)
134.83(6−C)
150.41(2−C)
163.82(4−C)
170.32(
CH3CO−)(2) 5'-acetyl-3'-deoxy-3'-fluorothymidine Melting point: 99-100°C 1H-nuclear magnetic resonance spectrum (DMSO=
d6) δ (ppm) = 1.90 (d, J =
1.22HZ, 3H, CH3)
2.09(s,3H,CH3CO-
) 2.23
(m, 1H, 2'-H)
2.62 (m, 1H, 2'-H)
4.36 (m, 2H
,5'-H)
4.37 (m, 1H, 4'-H)
5.18 (dd, JHH=5.
3HZ, JHF=51.6HZ,
3'-H)
6.30 (
dd, J=8.8HZ, J=55HZ, 1'-H)
7.22(d,
J=1.22HZ, 6-H)
9.21 (brS, 1H, >NH)
13C-Nuclear Magnetic Resonance Spectrum (DMSO-
d6) δ (ppm) = 12.43 (CH3
) 20.5
5(CH3CO-)
38.12 (d, J=21.3HZ, 2'-C
) 63.4
4 (d, J=10.2HZ, 5'-C)
82.37 (d, J=26
.. 7HZ, 4'-C)
85.47 (1'-C)
93.44 (d, J=180.
6HZ, 3'-C)
111.57 (5-C)
134.83 (6-C)
150.41 (2-C)
163.82 (4-C)
170.32 (
CH3CO-)
【0010】
(3)3’−デオキシ−3’−フルオロチミジン融点:
177〜179℃
1H−核磁気共鳴スペクトル(DMSO−
d6) δ(ppm)=1.77(d,J=
1.1HZ,CH3)
2.30(m,2H,H−2’×2)
3.64(m,2
H,H−5’×2)
4.13(td,JHH=4.0HZ,JHF
=27.8HZ,
1H,H−4’)
5.29(dd
,JHH=4.0HZ,JHF=54.2HZ,
1H,H−3’)
6.20(dd,J=5.9HZ,J=9.
1HZ,1H,
H−1’)
7.69(d,J=1.1H
Z,1H,H−6)
11.31(brS,1H,>NH)
13C−核磁気共鳴スペクトル(DMSO−d6)
δ(ppm)=12.16(CH3)
36.94(d,J
=20.3HZ,2’−C)
60.94(d,J=11.1HZ,
5’−C)
83.89(1’−C)
84.94(d,J=23.0HZ,4’
−C) 95
.03(d,J=174.4HZ,3’−C)
110.00(5−C)
136.04(
6−C) 150
.82(2−C)
164.03(4−C) 比施度〔α〕(26゜/
D)−7.0°(c=1.0,DMSO)(3) 3'-deoxy-3'-fluorothymidine melting point:
177-179°C 1H-Nuclear Magnetic Resonance Spectrum (DMSO-
d6) δ (ppm) = 1.77 (d, J =
1.1Hz, CH3)
2.30 (m, 2H, H-2'x2)
3.64 (m, 2
H, H-5'×2)
4.13 (td, JHH=4.0HZ, JHF
=27.8Hz,
1H,H-4')
5.29 (dd
, JHH=4.0HZ, JHF=54.2HZ,
1H,H-3')
6.20 (dd, J=5.9HZ, J=9.
1HZ, 1H,
H-1')
7.69 (d, J=1.1H
Z, 1H, H-6)
11.31 (brS, 1H, >NH)
13C-Nuclear Magnetic Resonance Spectrum (DMSO-d6)
δ (ppm) = 12.16 (CH3)
36.94 (d, J
=20.3Hz, 2'-C)
60.94 (d, J=11.1HZ,
5'-C)
83.89 (1'-C)
84.94 (d, J=23.0Hz, 4'
-C) 95
.. 03 (d, J=174.4HZ, 3'-C)
110.00 (5-C)
136.04 (
6-C) 150
.. 82 (2-C)
164.03 (4-C) Ratio [α] (26°/
D) -7.0° (c=1.0, DMSO)
【0011】
実施例2
3’−デオキシ−3’−フルオロ−5’−メシルチミジ
ン3.22g(10mmol)をN,N−ジメチルホル
ムアミド10mlに溶解する。この溶液に酢酸カリウム
1.96g(20m mol)を加え、110°±5
℃で60分間撹拌下に加熱した。反応終了後、減圧下に
N,N−ジメチルホルムアミドを留去し、残渣に水30
mlを加えこれを酢酸エチル50mlで2回抽出した。
酢酸エチル層を水30mlで2回洗浄し、無水硫酸ナト
リウムで乾燥後、減圧下に酢酸エチルを留去し、残渣を
メタノールに溶解した。この溶液に活性炭1.4gを加
え脱色ののち濾過し、濾液を濃縮し残渣を得る。残渣を
実施例1と同様にアンモニア飽和メタノールで処理した
のち、精製操作を行い、白色粒状結晶の3’−デオキシ
−3’−フルオロチミジン1.8g(7.38m m
ol)を得た。収率73.8%。分析値は実施例1で得
た3’−デオキシ−3’−フルオロチミジンと同一であ
る。[0011]
Example 2 3.22 g (10 mmol) of 3'-deoxy-3'-fluoro-5'-mesylthymidine is dissolved in 10 ml of N,N-dimethylformamide. Add 1.96 g (20 mmol) of potassium acetate to this solution and mix at 110°±5
Heat with stirring at 0.degree. C. for 60 minutes. After the reaction, N,N-dimethylformamide was distilled off under reduced pressure, and 30% of water was added to the residue.
ml was added and extracted twice with 50 ml of ethyl acetate. The ethyl acetate layer was washed twice with 30 ml of water, dried over anhydrous sodium sulfate, then ethyl acetate was distilled off under reduced pressure, and the residue was dissolved in methanol. 1.4 g of activated carbon is added to this solution to decolorize it, and then filtered, and the filtrate is concentrated to obtain a residue. The residue was treated with ammonia-saturated methanol in the same manner as in Example 1, and then purified to yield 1.8 g of 3'-deoxy-3'-fluorothymidine (7.38 m m ) as white granular crystals.
ol) was obtained. Yield 73.8%. The analytical values are the same as for 3'-deoxy-3'-fluorothymidine obtained in Example 1.
【0012】実施例3
3’−デオキシ−3’−フルオロ−5’−メシルチミジ
ン644g(2mol)をN,N−ジメチルホルムアミ
ド1リットルに溶解する。この溶液に酢酸アンモニウム
308g(4mol)を加え、110°±5℃で2時間
撹拌下に加熱した。反応終了後、反応混合物より減圧下
にN,N−ジメチルホルムアミドを留去し、残渣として
褐色油状物約1kgを得た。この褐色油状物は実施例1
と同様の高速液体クロマトグラフィー、薄層クロマトグ
ラフィー、核磁気共鳴スペクトルの結果から、5’−ア
セチル−3’−デオキシ−3’−フルオロチミジンであ
ることを確認した。次に、この褐色油状物にアンモニア
飽和メタノール溶液6リットルを加え、室温で約2時間
撹拌後、減圧下にメタノールを留去し、褐色油状物約1
kgを得た。次いでこの褐色油状物を水10リットルに
溶解後、この溶液を合成吸着剤セパビーズSP207(
登録商標)10リットルに通液し吸着させる。次にこの
合成吸着剤に水30リットルを通液して洗浄後、50%
メタノール−水混液30リットル、メタノール10リッ
トルを順次通液して溶出・洗浄する。このメタノール−
水混液溶出液を減圧下に濃縮乾固し、残渣として白色固
体の3’−デオキシ−3’−フルオロチミジンの粗結晶
約450gを得た。次にこの白色固体に水2リットルを
加え撹拌下に加熱溶解後、室温下で一夜撹拌し、白色粉
末状結晶の3’−デオキシ−3’−フルオロチミジン4
10g(1.68mol)を得た。収率84%。 分
析値は実施例1で得た3’−デオキシ−3’−フルオロ
チミジンと同一である。Example 3 644 g (2 mol) of 3'-deoxy-3'-fluoro-5'-mesylthymidine is dissolved in 1 liter of N,N-dimethylformamide. 308 g (4 mol) of ammonium acetate was added to this solution, and the mixture was heated at 110°±5° C. for 2 hours with stirring. After the reaction was completed, N,N-dimethylformamide was distilled off from the reaction mixture under reduced pressure to obtain about 1 kg of brown oil as a residue. This brown oil was obtained from Example 1.
From the results of high performance liquid chromatography, thin layer chromatography, and nuclear magnetic resonance spectroscopy similar to those described above, it was confirmed that it was 5'-acetyl-3'-deoxy-3'-fluorothymidine. Next, 6 liters of ammonia-saturated methanol solution was added to this brown oil, and after stirring at room temperature for about 2 hours, methanol was distilled off under reduced pressure, and about 1 liter of ammonia-saturated methanol solution was added.
I got kg. Next, after dissolving this brown oil in 10 liters of water, this solution was added to the synthetic adsorbent Sepabead SP207 (
(Registered Trademark) 10 liters for adsorption. Next, after washing by passing 30 liters of water through this synthetic adsorbent, 50%
30 liters of methanol-water mixture and 10 liters of methanol were passed through the solution in sequence for elution and washing. This methanol-
The water mixture eluate was concentrated to dryness under reduced pressure to obtain about 450 g of crude crystals of 3'-deoxy-3'-fluorothymidine as a white solid as a residue. Next, 2 liters of water was added to this white solid, and after heating and dissolving with stirring, the mixture was stirred overnight at room temperature, and 3'-deoxy-3'-fluorothymidine 4 was dissolved in white powdery crystals.
10 g (1.68 mol) was obtained. Yield 84%. The analytical values are the same as for 3'-deoxy-3'-fluorothymidine obtained in Example 1.
【0013】実施例4
3’−デオキシ−3’−フルオロ−5’−メシルチミジ
ン322g(1mol)をジメチルスルホキシド500
mlに溶解し、この溶液に酢酸テトラメチルアンモニウ
ム266g(2mol)を加え、110°±5℃で30
分間撹拌下に加熱した。反応終了後、反応混合物より減
圧下にジメチルスルホキシドを留去し、残渣として褐色
油状物約500gを得た。この褐色油状物は実施例1と
同様の高速液体クロマトグラフィー、薄層クロマトグラ
フィー、核磁気共鳴スペクトルの結果から、5’−アセ
チル−3’−デオキシ−3’−フルオロチミジンである
ことを確認した。次に、この褐色油状物にアンモニア飽
和メタノール溶液3リットルを加え、室温で約2時間撹
拌後、減圧下にメタノールを留去し、褐色油状物約50
0gを得た。次いでこの褐色油状物を水5リットルに溶
解後、合成吸着剤ダイヤイオンHP20(登録商標)5
リットルに通液し吸着させる。次にこの合成吸着剤を実
施例3と同様に処理し、白色粉末状結晶の3’−デオキ
シ−3’−フルオロチミジン195g(0.80mol
)を得た。収率80%。分析値は実施例1で得た3’−
デオキシ−3’−フルオロチミジンと同一である。Example 4 322 g (1 mol) of 3'-deoxy-3'-fluoro-5'-mesylthymidine was dissolved in 500 g of dimethyl sulfoxide.
ml, add 266 g (2 mol) of tetramethylammonium acetate to this solution, and stir at 110°±5°C for 30
Heat with stirring for minutes. After the reaction was completed, dimethyl sulfoxide was distilled off from the reaction mixture under reduced pressure to obtain about 500 g of a brown oil as a residue. This brown oil was confirmed to be 5'-acetyl-3'-deoxy-3'-fluorothymidine from the results of high performance liquid chromatography, thin layer chromatography, and nuclear magnetic resonance spectroscopy similar to those in Example 1. . Next, 3 liters of ammonia-saturated methanol solution was added to this brown oil, and after stirring at room temperature for about 2 hours, methanol was distilled off under reduced pressure, and about 50 liters of ammonia-saturated methanol solution was added to the brown oil.
Obtained 0g. Next, after dissolving this brown oil in 5 liters of water, the synthetic adsorbent Diaion HP20 (registered trademark) 5 was added.
Pass the liquid through the liter to absorb it. Next, this synthetic adsorbent was treated in the same manner as in Example 3, and 195 g (0.80 mol.
) was obtained. Yield 80%. The analytical value is 3'- obtained in Example 1.
Identical to deoxy-3'-fluorothymidine.
【0014】比較例
3’−デオキシ−3’−フルオロ−5’−メシルチミジ
ン0.5g(1.6mmol)を無水酢酸60mlに溶
解し、この溶液に酢酸カリウム0.5g(5.1m
mol)を加え、130〜135℃で2時間撹拌下に加
熱した。反応終了後、減圧下に無水酢酸を留去し、濃赤
褐色の残渣をクロロホルム125mlに溶解したのち、
水100mlで洗浄し、更にクロロホルム層を活性炭0
.1gで処理して脱色し、硫酸マグネシウムを用い乾燥
する。次いでクロロホルムを留去して残渣として赤褐色
油状物0.73gを得た。この赤褐色油状物を高速液体
クロマトグラフィーで分析した結果、27個のピークを
検出し、うち、5’−アセチル−3’−デオキシ−3’
−フルオロチミジンの含有量は20%(面積比)であっ
た。Comparative Example 3 0.5 g (1.6 mmol) of deoxy-3'-fluoro-5'-mesylthymidine was dissolved in 60 ml of acetic anhydride, and 0.5 g (5.1 mmol) of potassium acetate was added to this solution.
mol) was added and heated at 130-135°C for 2 hours with stirring. After the reaction was completed, acetic anhydride was distilled off under reduced pressure, and the dark reddish brown residue was dissolved in 125 ml of chloroform.
Wash with 100ml of water, and remove the chloroform layer with activated carbon.
.. 1 g to decolorize and dry using magnesium sulfate. Then, chloroform was distilled off to obtain 0.73 g of a reddish-brown oil as a residue. As a result of analyzing this reddish brown oil by high performance liquid chromatography, 27 peaks were detected, among which 5'-acetyl-3'-deoxy-3'
- The content of fluorothymidine was 20% (area ratio).
【0015】[0015]
【発明の効果】本発明の3’−デオキシ−3’−フルオ
ロチミジンの製造法は、それ自身が抗ウィルス作用、抗
腫瘍作用を有する化合物として有用であり、特に抗エイ
ズ薬である3’−デオキシ−3’−アジドチミジン(A
ZT)と比較し強い抗エイズウィルス活性を示す3’−
デオキシ−3’−フルオロチミジンを高収率で、簡便に
かつ大量に安定して供給できるものであり、工業的な製
法として適している。Effects of the Invention The method for producing 3'-deoxy-3'-fluorothymidine of the present invention is useful as a compound that itself has antiviral and antitumor effects, and is particularly useful for producing 3'-deoxy-3'-fluorothymidine, which is an anti-AIDS drug. Deoxy-3'-azidothymidine (A
3'- which shows stronger anti-AIDS virus activity compared to ZT)
This method can stably supply deoxy-3'-fluorothymidine in a high yield, simply and in large quantities, and is suitable as an industrial production method.
Claims (1)
ジンの製造法において、3’−デオキシ−3’−フルオ
ロ−5’−メシルチミジンを非プロトン性極性溶媒中で
、酢酸アルカリ金属塩、酢酸アミン類および酢酸アンモ
ニウムからなる群より選択されるアセチル化試薬と反応
させて5’−アセチル−3’−デオキシ−3’−フルオ
ロチミジンを得る工程と、この5’−アセチル−3’−
デオキシ−3’−フルオロチミジンを脱アセチル化して
3’−デオキシ−3’−フルオロチミジンを得る工程と
からなることを特徴とする3’−デオキシ−3’−フル
オロチミジンの製造法。Claim 1. A method for producing 3'-deoxy-3'-fluorothymidine, in which 3'-deoxy-3'-fluoro-5'-mesylthymidine is treated in an aprotic polar solvent with an alkali metal salt of acetate, an acetic acid a step of reacting with an acetylating reagent selected from the group consisting of amines and ammonium acetate to obtain 5'-acetyl-3'-deoxy-3'-fluorothymidine;
A method for producing 3'-deoxy-3'-fluorothymidine, which comprises the step of deacetylating deoxy-3'-fluorothymidine to obtain 3'-deoxy-3'-fluorothymidine.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/736,928 US5166327A (en) | 1990-07-31 | 1991-07-29 | Process for producing 3'-deoxy-3-'-fluorothymidine |
DE69123201T DE69123201T2 (en) | 1990-07-31 | 1991-07-31 | Process for the preparation of 3'-deoxy-3'-fluorothymidine |
EP91112886A EP0472019B1 (en) | 1990-07-31 | 1991-07-31 | Process for producing 3'-deoxy-3'-fluorothymidine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20372990 | 1990-07-31 | ||
JP2-203729 | 1990-07-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04217692A true JPH04217692A (en) | 1992-08-07 |
JP3023804B2 JP3023804B2 (en) | 2000-03-21 |
Family
ID=16478889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP03023988A Expired - Fee Related JP3023804B2 (en) | 1990-07-31 | 1991-01-24 | Method for producing 3'-deoxy-3'-fluorothymidine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3023804B2 (en) |
-
1991
- 1991-01-24 JP JP03023988A patent/JP3023804B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3023804B2 (en) | 2000-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2318423B1 (en) | Process for making 5-azacytosine nucleosides and their derivatives | |
JPS63165394A (en) | Production of sucrose derivative | |
JPS61204193A (en) | Production of cytosine nuceoside | |
JPH0797391A (en) | Nucleoside derivative and its production | |
JP3029806B2 (en) | Glycosidation of colchicine derivative and product thereof | |
JP4253858B2 (en) | Fullerene derivative and method for producing the same | |
JPH04217692A (en) | Production of 3'-deoxy-3'-fluorothymidine | |
JPH0217199A (en) | Production of 2'-deoxy-beta-adenosine | |
WO2020029647A1 (en) | Method for synthesizing nucleoside compound and intermediate thereof | |
EP0472019B1 (en) | Process for producing 3'-deoxy-3'-fluorothymidine | |
US20080262214A1 (en) | Synthesis of 2-Substituted Adenosines | |
KR100446560B1 (en) | Method for Producing 2-Deoxy-L-ribose | |
JPH07165785A (en) | Preparation of 3'-fluoropyrimidine nucleoside | |
JPS61263995A (en) | Production of cytosine nucleoside | |
CN112142629B (en) | Preparation method of 3-aminosulfonylalanine | |
CN116589475B (en) | Preparation method of 2',4',5',7' -tetrachloro-5 (6) -carboxyl-4, 7-dichloro fluorescein | |
JPH03227997A (en) | Production of nucleoside derivative | |
CN116462719A (en) | Process for preparing deoxynucleosides of alpha configuration | |
CN113549121A (en) | Preparation method of nucleoside modifier | |
CN112500441A (en) | Preparation process of high-purity glycosyl phosphate | |
CN117024485A (en) | Synthesis method of 2' -OMe adenosine | |
CN115636854A (en) | Method for synthesizing sialic acid chloro glycoside compound | |
JPH03190894A (en) | Production of nucleoside derivative by selective hydrolysis | |
JPS60152494A (en) | Preparation of protected nucleotide compound | |
JPS58194895A (en) | Improved method for preparing na salt of dbc-amp (n6,2'-o-dibutyryladenosine-3,5'-cyclic phosphate) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090121 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100121 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110121 Year of fee payment: 11 |
|
LAPS | Cancellation because of no payment of annual fees |